07 Jan 2001

Efudix 5% - España

Updated: 07 Jan 2001

Efudix 5% pomada 20 g

Alteraciones cutáneas precancerosas o cancerosas, tales como: queratosis solar y senil, enfermedad de Bowen, epiteliomas basocelulares superficiales simples o múltiples.

Efudix 5% Description, Presentation and Dosage

Efudix 5% Description

Efudix 5% Drug Class Description

Antineoplasicos: antimetabolitos

Efudix 5% Drug Description

POMADA

Efudix 5% Presentation

Efudix 5% Presentation

Tópica. Aplicar una fina capa de pomada al 5% 1 vez al día durante 3-4 semanas. En la queratosis solar o senil se debe aplicar sin vendaje. En otras afecciones se recomienda la aplicación de un vendaje oclusivo, que se renovará diariamente.

Efudix 5% Manufacturer

Valeant Pharmaceuticals Ltd

Related Learning Zones

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Efudix 5% Dosage

Efudix 5% Precautions, Reactions and Contraindications

Efudix 5% Special Precautions

Efudix 5% Special Precautions

Dermatosis preexistentes, especialmente cloasma y rosácea. No aplicar sobre membranas mucosas: ojos, nariz, boca. Los vendajes oclusivos aumentan la reacción inflamatoria sobre la piel sana adyacente a la lesión. No es recomendable una exposición prolongada al sol ante el riesgo de que puedan producirse manifestaciones de fotosensibilidad.

Efudix 5% Adverse Reactions

Efudix 5% Adverse Reactions

Sensación de quemazón en el lugar de aplicación, prurito, enrojecimiento, tumefacción, fotosensibilidad, erupciones cutáneas. Ocasionalmente: hiperpigmentación, descamación y dermatitis de contacto.

Efudix 5% Contraindications

Efudix 5% Contraindications

Hipersensibilidad al medicamento. Embarazo.

Related Drugs - Trastornos musculoesqueléticos

Back to top